Boston Clinical Trials Llc

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Depression2 trials

Phase

• Phase 32 trials
• Phase 21 trial
• Phase 2/31 trial

Status

• Active, not recruiting2 trials
• Terminated2 trials

Lead sponsor

• Neurocentria, Inc.2 trials
• Xenon Pharmaceuticals Inc.2 trials

Running trials

• Active, not recruiting

  An Open-Label Study of Azetukalner in Major Depressive Disorder

  NCT06922110· Phase 3· Xenon Pharmaceuticals Inc.· Source

• Active, not recruiting

  A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder

  NCT06775379· Phase 3· Xenon Pharmaceuticals Inc.· Source

Closed trials

• Terminated

  A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR With NRCT-202XR Compared to NRCT-202XR Alone in Subjects With Attention-Deficit/Hyperactivity Disorder

  NCT06673368· Phase 2· Neurocentria, Inc.· Source

• Terminated

  Study to Evaluate NRCT-101SR in Pediatric Subjects With ADHD

  NCT06215144· Phase 2/3· Neurocentria, Inc.· Source